Lupin (LUPIN) | Stock Overview & Key Data
Lupin Performance Comparison
Stock Range
Today's Range
Low: ₹1,969.10
High: ₹2,006.10
on October 3, 2025
52 Week Range
Low: ₹1,795.20
High: ₹2,402.90
on April 7, 2025
on January 2, 2025
All-Time High: ₹2,402.90 on December 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR873.4B
EPS
81.39
P/E Ratio (TTM)
23.48
Forward P/E
23.38
P/B Ratio
5.07
PEG Ratio
0.45
Div. Yield
0.62%
ROE
18.98%
Beta
0.303
Debt to Equity
31.50
Financial Highlights
Profitability
Gross Margin
71.25%
Operating Margin
23.23%
Profit Margin
15.83%
Returns and Earnings
Return on Assets (TTM)
11.24%
Return on Equity (TTM)
18.98%
EBITDA
INR60.3B
Net Income (TTM)
INR37.0B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR512.00
Quarterly Revenue Growth (YoY)
11.90%
Quarterly Earnings Growth (YoY)
52.10%
Dividend Information
Last 12-Month Dividend
₹12.00
Current Dividend Yield
0.62%
3-Year Average Dividend Yield
0.50%
3-Year Average Annual Dividend
₹8.00
3-Year Total Dividends
₹24.00
Ex-Dividend Date
July 25, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lupin LUPIN | 873.43B Large-cap | -0.48% | 4.39% | 1.04% | 1.32% | -16.22% | -9.87% | 174.72% | 92.51% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 0.56% | 4.66% | -1.86% | -3.66% | -13.43% | -14.34% | 71.30% | 219.01% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | -4.58% | -6.29% | -16.72% | 2.89% | -5.98% | 5.24% | 52.85% | 79.00% |
| Torrent TORNTPHARM | 1.24T Large-cap | -1.31% | -0.48% | 4.40% | 12.04% | 4.35% | 2.69% | 126.86% | 27.41% |
| Cipla CIPLA | 1.22T Large-cap | -1.63% | -4.67% | -0.18% | 4.76% | 2.27% | 5.11% | 33.83% | 88.38% |
| Dr. Reddy's DRREDDY | 1.05T Large-cap | -4.11% | -2.75% | -2.51% | 8.03% | -9.08% | -6.18% | 42.20% | 20.77% |
Ownership & Short Interest
Insider Ownership
47.27%
Institutional Ownership
36.05%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
829K
Average 90-Day Volume
691K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LUPIN's 52-week high and low?
- In the last 52 weeks, Lupin reached a high of ₹2,402.90 (on January 2, 2025) and a low of ₹1,795.20 (on April 7, 2025).
- What is the market cap and P/E ratio for LUPIN?
- Curious about Lupin's size and valuation? Its market capitalization stands at 873.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is 23.48, and the forward P/E (looking ahead) is 23.38.
- Does LUPIN pay dividends? If so, what's the yield?
- Yes, Lupin is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.62%, and the company has paid an average of ₹8.00 per share annually over the past 3 years.
- Who are Lupin's main competitors or similar companies to consider before investing?
When looking at Lupin, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -14.34% 71.30% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic 5.24% 52.85% Torrent
TORNTPHARM1.24T Healthcare Drug Manufacturers - Specialty & Generic 2.69% 126.86% Cipla
CIPLA1.22T Healthcare Drug Manufacturers - Specialty & Generic 5.11% 33.83% Dr. Reddy's
DRREDDY1.05T Healthcare Drug Manufacturers - Specialty & Generic -6.18% 42.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lupin Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Lupin's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.98%, the Debt to Equity ratio from the most recent quarter is 31.50, and its Gross Profit Margin stands at 71.25%.
- What is the recent revenue and earnings growth for LUPIN?
- Looking at Lupin's growth, its revenue over the trailing twelve months (TTM) was INR234B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.90%, and quarterly earnings saw a YoY growth of 52.10%.
- How much of LUPIN stock is held by insiders and institutions?
- Wondering who owns Lupin stock? Company insiders (like executives and directors) hold about 47.27% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 36.05%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.